Kicking off Day 1 at #CX2024 on 23 April, will be the monumental #BASIL -3 Podium First Presentation which will focus on the trial's clinical results and health economics data!

Andrew Bradbury Gareth Bate @catmoakes @Kjesse14

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy #ISET2024 for TCTMD #CLTI Barry T. Katzen, MD BEST-CLI Trial Andrew Bradbury Mehdi Shishehbor, DO Darren Schneider, MD tctmd.com/news/how-recon…

Check out this great summary of a very important landmark trial. Also, check out this video where we take a deeper dive into the study. m.youtube.com/watch?v=YYkCwr…

Looking forward to participating in this important meeting. Thank you so much to ALPS for inviting me! limbpreservationsociety.org/dfcon.

Luis A. Navarro Garzon (Vascular Academic Lead) Daniel Carradice Vascular Society Education And Training Committee Andrew Bradbury Athanasios Saratzis Kaji Sritharan What does “clinical uncertainty with infrapopliteal disease” mean?

Such a well written article containing a number of hugely important messages vascular.org/news-advocacy/…

The 'general great bloke' is the take home message here👇🏻😁

Many congratulations to my friend Thanos Saratzis who has today been promoted to the position of Professor of Vascular Surgery University of Leicester Uni of Leicester Cardiovascular Sciences Endovascular pioneer, international research leader and general great bloke.

viva-foundation.org/viva1

Beyond Wires and Knives: What Can We Learn From BEST-CLI and BASIL-2? Interpretation of two major trials. Free access 👉🏼 authors.elsevier.com/a/1hJjL_OXZN%7… with GermanVasc@CA_Behrendt & Martin Björck in EJVES @CouncilPvd @StandAgainstAmp ANZSVS

It is still not too late to register for both the National Vascular Training Day and the BSET . Annual Conference.

I shall be involved in the Carotid Disease and EVAR modules and look forward to meeting everyone next week!

#RouleauxClub lnkd.in/ejjzstdF

Couldn't agree more!

'Note if a patient falls within the inclusion criteria for a trial, they SHOULD be offered participation as part of their treatment. Being in a trial is a valid treatment option.'
👇🏻💯👌🏻

Huge congratulations to Alik and Matt for their amazing achievements with BEST-CLI

acrobat.adobe.com/id/urn:aaid:sc…
Excellent overview from Dr Mike Conte. Really looking forward to 15 June at SVS VAM

An excellent update on CLTI trials BEST CLI and BASIL-2 as we speak.

Also worth catching up on this excellent video with the chief investigator of BASIL-2 Andrew Bradbury excellently chaired by Daniel Carradice

Athanasios Saratzis Kaji Sritharan

youtube.com/watch?v=YYkCwr…

Really important that this survey gets as wide a response as possible. If you are involved in diabetes foot care, please do spare a few minutes to participate. VSGBI Diabetic Foot Special Interest Group Vascular Society English Diabetes Footcare Network @fduk

Thanks Helen, a great reminder to promote this further.

SVN (Society of Vascular Nurses) SVTGBI BACPAR LegsMatter Lindsay Leg Club Foundation Vascular and Venous All-Party Parliamentary Group

youtu.be/YYkCwrihLlk

A fascinating insight into the world of Basil-2. Brilliant for the Research Nurses involved in the study.

Seems we need to feed backward to ensure patients with risk factors receive proper CLTI medicines.

sciencedirect.com/science/articl…

Lisa Kelly, BASIL Research Nurse at Solihull Research Showcase – celebrating BASIL trials for International Trials Day! #bepartofresearch